Stocks and Investing Stocks and Investing
Thu, November 11, 2021
Wed, November 10, 2021
Tue, November 9, 2021
Mon, November 8, 2021

Salveen Richter Downgraded (BLUE) to Strong Sell and Decreased Target to $10 on, Nov 8th, 2021


Published on 2024-10-27 18:34:10 - WOPRAI
  Print publication without navigation


Salveen Richter of Goldman Sachs, Downgraded "bluebird bio, Inc." (BLUE) to Strong Sell and Decreased Target from $23 to $10 on, Nov 8th, 2021.

Salveen has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 2 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • John Newman of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $20 on, Tuesday, August 10th, 2021
  • Yanan Zhu of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $25 on, Tuesday, August 10th, 2021


This is the rating of the analyst that currently disagrees with Salveen


  • Difei Yang of "Mizuho" Maintained at Strong Buy with Decreased Target to $23 on, Wednesday, September 22nd, 2021